The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 65.00
Ask: 70.00
Change: 1.00 (1.50%)
Spread: 5.00 (7.692%)
Open: 66.50
High: 67.50
Low: 66.50
Prev. Close: 66.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Adviser

28 Jul 2016 07:00

RNS Number : 4527F
NetScientific PLC
28 July 2016
 

 

 

("NetScientific" or the "Company" or the "Group")

 

Change of Adviser

 

London, UK - 28 July 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic biomedical and healthcare technology group, is pleased to announce the appointment of Stifel Nicolaus Europe Limited as Nominated Adviser and Broker to the Company with immediate effect.

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

Stifel Nicolaus Europe Limited (NOMAD and broker) Jonathan Senior / David Arch / Ben Maddison

Tel: +44 (0) 20 7710 7600

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPLLFVTDFIDFIR
Date   Source Headline
21st Dec 201811:04 amRNSForm 8.5 - NetScientific PLC
20th Dec 20184:41 pmRNSSecond Price Monitoring Extn
20th Dec 20184:36 pmRNSPrice Monitoring Extension
20th Dec 201810:28 amRNSForm 8.5 - NetScientific PLC
20th Dec 20187:00 amRNSUpdate on Strategic Review
19th Dec 201811:03 amRNSForm 8.3 - NetScientific Plc
19th Dec 201811:00 amRNSForm 8.3 - NetScientific plc
19th Dec 20189:34 amRNSForm 8.5 - NetScientific PLC
18th Dec 20189:32 amRNSForm 8.5 - NetScientific PLC
13th Dec 20189:06 amRNSForm 8.5 - NetScientific PLC
7th Dec 201810:23 amRNSForm 8.5 - NetScientific PLC
5th Dec 20189:14 amRNSForm 8.5 - NetScientific PLC
4th Dec 20189:50 amRNSForm 8.5 - NetScientific PLC
3rd Dec 201810:31 amRNSForm 8.5 - NetScientific PLC
30th Nov 20183:46 pmRNSForm 8 (OPD) - NetScientific (Offeree)
30th Nov 201811:35 amRNSForm 8.5 - NetScientific PLC
29th Nov 20181:29 pmRNSForm 8.3 - NetScientific Plc
29th Nov 201812:49 pmRNSForm 8.3 - NetScientific Plc
29th Nov 201810:26 amRNSForm 8.5 - NetScientific PLC
28th Nov 20181:46 pmRNSForm 8.3 - NetScientific Plc
28th Nov 20189:51 amRNSForm 8.5 - NetScientific PLC
27th Nov 201812:44 pmGNWInvesco Ltd.: Form 8.3 - Netscientific Plc
27th Nov 201812:34 pmRNSForm 8.3 - NetScientfic Plc
27th Nov 201810:33 amRNSForm 8.5 - NetScientific PLC
27th Nov 20189:36 amRNSForm 8.3 - NetScientific PLC
26th Nov 20183:01 pmRNSAmendment to Executive Director Service Terms
26th Nov 20183:00 pmRNSAnnouncement of Strategic Review
26th Nov 201812:30 pmRNSPDS Announces Merger with Edge Therapeutics
8th Nov 20187:00 amRNSVortex Improves CTC Enumeration with Impedance
1st Nov 20187:00 amRNSVortex and STRATEC Announce Global Partnership
22nd Oct 20181:01 pmRNSGlycotest Completes $10m Series A Round with Fosun
22nd Oct 20187:00 amRNSGlycotest Completes $10m Series A Round with Fosun
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSProAxsis Immunoassays Selected for Large Trial
15th Aug 20187:00 amRNSWanda Launches CareLink, New Digital Health App
2nd Aug 20187:02 amRNSProAxsis Granted Third Respiratory Field CE Mark
2nd Aug 20187:00 amRNSChange of Adviser
18th Jul 20187:00 amRNSWanda Technology Enhancements
26th Jun 20184:24 pmRNSGrant of Options to Directors
21st Jun 20181:33 pmRNSResult of AGM
6th Jun 20187:00 amRNSBob Englert Appointed CEO of Vortex Biosciences
4th Jun 20187:00 amRNSProAxsis Wins Innovative Business of Year in NI
1st Jun 20187:00 amRNSProAxsis Awarded Invest NI Grant
22nd May 20184:21 pmRNSNotice of AGM and Annual Report & Accounts
21st May 20187:00 amRNSWanda Announces Significant Data with Partner HRS
2nd May 20187:00 amRNSProAxsis to Present New Data at ATS 2018
18th Apr 20185:08 pmRNSDirectors Dealing Notification
16th Apr 20182:04 pmRNSResult of General Meeting
16th Apr 20187:25 amRNSVortex to Present 2 Posters at AACR
11th Apr 201811:39 amRNSResult of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.